| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
OPCH Stock Overview
Option Care Health, Inc. offers home and alternate site infusion services in the United States.
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$22.06 |
| 52 Week High | US$28.86 |
| 52 Week Low | US$16.02 |
| Beta | 1.86 |
| 1 Month Change | -21.10% |
| 3 Month Change | -17.81% |
| 1 Year Change | 12.61% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 99.10% |
Recent News & Updates
At US$25.88, Is Option Care Health, Inc. (NASDAQ:OPCH) Worth Looking At Closely?
While Option Care Health, Inc. ( NASDAQ:OPCH ) might not be the most widely known stock at the moment, it received a...
Here's Why Option Care Health (NASDAQ:OPCH) Can Manage Its Debt Responsibly
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Option Care Health (NASDAQ:OPCH) Shareholders Will Want The ROCE Trajectory To Continue
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...
Shareholder Returns
| OPCH | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -9.3% | -3.5% | -6.1% |
| 1Y | 12.6% | 12.7% | 4.2% |
Return vs Industry: OPCH matched the US Healthcare industry which returned 12.7% over the past year.
Return vs Market: OPCH exceeded the US Market which returned 4.2% over the past year.
Price Volatility
| OPCH volatility | |
|---|---|
| OPCH Average Weekly Movement | 5.3% |
| Healthcare Industry Average Movement | 8.0% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.4% |
Stable Share Price: OPCH is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: OPCH's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 5,499 | John Rademacher | https://www.optioncarehealth.com |
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications.
Option Care Health Fundamentals Summary
| OPCH fundamental statistics | |
|---|---|
| Market Cap | US$3.97b |
| Earnings (TTM) | US$82.27m |
| Revenue (TTM) | US$3.32b |
48.2x
P/E Ratio1.2x
P/S RatioIs OPCH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OPCH income statement (TTM) | |
|---|---|
| Revenue | US$3.32b |
| Cost of Revenue | US$2.56b |
| Gross Profit | US$751.17m |
| Expenses | US$668.90m |
| Earnings | US$82.27m |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.46 |
| Gross Margin | 22.65% |
| Net Profit Margin | 2.48% |
| Debt/Equity Ratio | 102.9% |
How did OPCH perform over the long term?
See historical performance and comparisonValuation
Is Option Care Health undervalued compared to its fair value and its price relative to the market?
33.6%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: OPCH ($22.06) is trading below our estimate of fair value ($33.24)
Significantly Below Fair Value: OPCH is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: OPCH is poor value based on its PE Ratio (48.2x) compared to the US Healthcare industry average (19.9x).
PE vs Market: OPCH is poor value based on its PE Ratio (48.2x) compared to the US market (16.5x).
Price to Earnings Growth Ratio
PEG Ratio: OPCH is poor value based on its PEG Ratio (1.7x)
Price to Book Ratio
PB vs Industry: OPCH is overvalued based on its PB Ratio (3.6x) compared to the US Healthcare industry average (2.5x).
Future Growth
How is Option Care Health forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
28.5%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OPCH's forecast earnings growth (28.5% per year) is above the savings rate (2%).
Earnings vs Market: OPCH's earnings (28.5% per year) are forecast to grow faster than the US market (12.9% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: OPCH's revenue (7.6% per year) is forecast to grow slower than the US market (9.1% per year).
High Growth Revenue: OPCH's revenue (7.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: OPCH's Return on Equity is forecast to be low in 3 years time (14.6%).
Past Performance
How has Option Care Health performed over the past 5 years?
13.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: OPCH has high quality earnings.
Growing Profit Margin: OPCH became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: OPCH has become profitable over the past 5 years, growing earnings by 13.8% per year.
Accelerating Growth: OPCH has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: OPCH has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (32.5%).
Return on Equity
High ROE: OPCH's Return on Equity (7.5%) is considered low.
Financial Health
How is Option Care Health's financial position?
Financial Position Analysis
Short Term Liabilities: OPCH's short term assets ($811.2M) exceed its short term liabilities ($485.7M).
Long Term Liabilities: OPCH's short term assets ($811.2M) do not cover its long term liabilities ($1.2B).
Debt to Equity History and Analysis
Debt Level: OPCH's net debt to equity ratio (84.6%) is considered high.
Reducing Debt: Insufficient data to determine if OPCH's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: OPCH's debt is not well covered by operating cash flow (15%).
Interest Coverage: OPCH's interest payments on its debt are not well covered by EBIT (2.3x coverage).
Balance Sheet
Dividend
What is Option Care Health current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate OPCH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate OPCH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if OPCH's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if OPCH's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of OPCH's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
6.3yrs
Average management tenure
CEO
John Rademacher (54 yo)
4.42yrs
Tenure
US$694,171
Compensation
Mr. John C. Rademacher is the President of Option Care Health, Inc. (formerly known as Option Care Enterprises Inc.) and has serves as a Director since 2019. Mr. Rademacher is the Chief Executive Officer o...
CEO Compensation Analysis
Compensation vs Market: John's total compensation ($USD694.17K) is below average for companies of similar size in the US market ($USD5.28M).
Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.
Leadership Team
Experienced Management: OPCH's management team is seasoned and experienced (6.3 years average tenure).
Board Members
Experienced Board: OPCH's board of directors are considered experienced (3 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Option Care Health, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Option Care Health, Inc.
- Ticker: OPCH
- Exchange: NasdaqGS
- Founded: NaN
- Industry: Health Care Services
- Sector: Healthcare
- Implied Market Cap: US$3.968b
- Shares outstanding: 179.88m
- Website: https://www.optioncarehealth.com
Number of Employees
Location
- Option Care Health, Inc.
- 3000 Lakeside Drive
- Suite 300N
- Bannockburn
- Illinois
- 60015
- United States
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/01/23 23:19 |
| End of Day Share Price | 2022/01/21 00:00 |
| Earnings | 2021/09/30 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.